65,437 trials
Hot Flashes
Primary: Change From Baseline in Average Daily Frequency of Hot Flashes After 4 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo — -6.8…
Type 2 Diabetes Mellitus · Coronary Artery Disease
Primary: Collagen Induced Aggregation — 32 percentage of platelet aggregation
Lymphoma
Primary: Progression-Free Survival (PFS) — 4.8; 3.7; 1.8 months — p=<0.0001
Acne Vulgaris
Primary: Mean Change From Baseline to Week 2 in the Global Score of the Participant-completed Skindex-29 Quality of Life (QoL) Questionnaire — -4.9; -1.1 scores on a scale…
Diagnostic Imaging · Central Nervous System Diseases
Primary: Scores for Three Visualization Parameters (Contrast Enhancement, Border Delineation and Internal Morphology) for Combined Unenhanced/Gadobutrol-enhanced Magnetic…
Obesity · Overweight
Primary: Change in Body Weight — -3.9; -3.5 kg — p=0.441
Cranial Dura Repair
Primary: Absence of Cerebrospinal Fluid (CSF) Fistula and Pseudomeningocele — 57; 33 participants
Drug Interaction
Primary: Platelet Function as Assessed by the P2Y12 Reactivity Index — 56.1; 61.6; 56; 61 Percentage of platelet reactivity index
Healthy
Primary: Sensory Threshold for Pain — 45.8; 46.7; 45.0 mm Hg
Major Depressive Disorder
Primary: Change From Baseline in Children's Depression Rating Scale-Revised (CDRS-R) Total Score at Week 10 Endpoint — -24.3; -23.7; -24.3 units on a scale — p=0.999
Axial Spondyloarthritis
Primary: Number of Participants Achieving an Assessment of Spondyloarthritis International Society (ASAS) 40 Response — 14; 33 participants — p=<0.001
Persistent or Permanent Nonvalvular Atrial Fibrillation
Primary: Bleeding: Number of Patients With Any Bleeding Event, During Treatment Period — 55; 56 Participants
HIV
Primary: Change in CD4 T-cell Count — -57.1; -70.3 cells/µl
Dementia, Alzheimer Type
Primary: Change From Baseline in Neuropsychiatric Inventory (NPI) Psychosis Subscale Score at Week 10 in Acute Phase — 12.12; 12.29; -5.52; -6.55 Units on a scale — p=0.802
Bipolar Disorder
Primary: Time to Recurrence of Any Mood Symptoms (Manic or Depressive) Associated With Bipolar I Disorder — 85.0; 140.0; 541; 283.0 Days — p=0.017